Shriram Revankar Sells 3,000 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $62.71, for a total value of $188,130.00. Following the transaction, the senior vice president directly owned 73,274 shares in the company, valued at $4,595,012.54. This trade represents a 3.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Dolby Laboratories Trading Up 2.5%

NYSE DLB opened at $62.64 on Thursday. Dolby Laboratories has a 1-year low of $48.26 and a 1-year high of $75.66. The stock has a 50-day moving average of $54.00 and a 200-day moving average of $58.45. The firm has a market cap of $5.87 billion, a PE ratio of 26.66 and a beta of 0.80.

Dolby Laboratories (NYSE:DLB) last issued its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $305.00 million during the quarter, compared to analysts’ expectations of $311.96 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.Dolby Laboratories’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities research analysts forecast that Dolby Laboratories will post 3.26 earnings per share for the current fiscal year.

Dolby Laboratories declared that its Board of Directors has approved a stock repurchase program on Thursday, July 30th that permits the company to repurchase $350.00 million in outstanding shares. This repurchase authorization permits the electronics maker to repurchase up to 7% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s leadership believes its shares are undervalued.

Dolby Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were issued a $0.36 dividend. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 61.28%.

Wall Street Analyst Weigh In

DLB has been the subject of several analyst reports. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings cut shares of Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, August 13th. Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a report on Monday, June 15th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a report on Friday, July 31st. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Dolby Laboratories presently has an average rating of “Hold” and an average target price of $83.00.

Institutional Trading of Dolby Laboratories

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Paragon Capital Management Inc. purchased a new stake in shares of Dolby Laboratories in the 1st quarter worth about $1,306,000. Teacher Retirement System of Texas raised its stake in Dolby Laboratories by 19.1% in the fourth quarter. Teacher Retirement System of Texas now owns 115,772 shares of the electronics maker’s stock worth $7,435,000 after buying an additional 18,579 shares in the last quarter. Hsbc Holdings PLC raised its stake in Dolby Laboratories by 396.1% in the first quarter. Hsbc Holdings PLC now owns 31,259 shares of the electronics maker’s stock worth $1,875,000 after buying an additional 24,958 shares in the last quarter. Norges Bank purchased a new stake in Dolby Laboratories in the fourth quarter worth about $54,966,000. Finally, Pacer Advisors Inc. lifted its holdings in Dolby Laboratories by 8.0% in the first quarter. Pacer Advisors Inc. now owns 516,292 shares of the electronics maker’s stock worth $31,008,000 after buying an additional 38,389 shares during the period. Hedge funds and other institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.